Drug Risk Assessment Needs IoM Report To Synthesize Research – CERTs

The Institute of Medicine should study the current state of pharmaceutical risk assessment and recommend methodological and research improvements, participants in a Centers for Education & Research on Therapeutics risk assessment workshop suggested